Then, we immunohistochemically detected the expression of SMAD2 and EZH2 in 20 pairs of TNBC samples and paired paracancer specimens and found that the expression levels of SMAD2 and EZH2 were significantly increased in cancer tissues (Figures 4I–L). Here, SMAD2 is linked to cancer.